vTv Therapeutics (VTVT) – Hot FDA News
-
vTv Therapeutics (VTVT) Announces Part 2 of Phase 2 Simplici-T1 Study of TTP399 Achieved its Primary Objective
-
vTv Therapeutics (VTVT) Part B of Phase 3 STEADFAST Study in Alzheimer’s Disease Did Not Meet co-primary Efficacy Endpoints
-
-
Back to VTVT Stock Lookup